---
title: "Ayala Pharmaceuticals (ADXS.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ADXS.US/norm.md"
symbol: "ADXS.US"
name: "Ayala Pharmaceuticals"
parent: "https://longbridge.com/en/quote/ADXS.US.md"
datetime: "2026-03-13T20:31:22.012Z"
locales:
  - [en](https://longbridge.com/en/quote/ADXS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ADXS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ADXS.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/ADXS.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ADXS.US/norm.md)


# Ayala Pharmaceuticals (ADXS.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q4 2023 | Q3 2023 | Q3 2022 |
| --- | --- | --- | --- |
| EPS | -2.44 | -1.53 | -3.51 |
| ROE | - | - | - |
| Revenue | 0.0000 | - | 91000.00 |
| Net income | -24.67M | -7.34M | -10.19M |

## Balance Sheet (USD)

| Indicator | Q4 2023 | Q3 2023 | Q3 2022 |
| --- | --- | --- | --- |
| A&L | 16.58M | 6.98M | - |
| Leverage | -0.6790 | -1.12 | - |
| BVPS | -2.41 | -1.30 | - |
| Turnover | 0.0011 | - | - |

## Cash Flow Statement (USD)

| Indicator | Q4 2023 | Q3 2023 | Q3 2022 |
| --- | --- | --- | --- |
| Operating CF | -7.20M | - | - |
| Investing CF | 5.95M | - | - |
| Financing CF | 4.00M | - | - |
| Free CF | 149750.00 | - | - |